In the present study, the anti-VCA IgM (+) IgG (−) serological panel was used for sample screening; this profile is indicative of primary EBV infection, has high sensitivity, and is applied in the discrimination of false-positive cases [20]. The gene discussed is CD40LG; the disease is Epstein-Barr virus infection.